Stay updated on Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help/navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention / Treatment label has been reformatted to Intervention/Treatment, and the page version now shows Revision: v3.6.0.SummaryDifference0.3%

- Check19 days agoChange DetectedThe page's revision metadata was updated to v3.5.5 (replacing v3.5.4). This indicates an administrative update to the study record's version tag without altering the study content.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision metadata updated from v3.5.3 to v3.5.4, signaling a new release of the page content. This update reflects a version change rather than a substantive modification to the study details or functionality.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site software/version release rather than a change to the clinical trial information.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.